These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8243351)

  • 1. Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot trial.
    Medina MT; Genton P; Montoya MC; Córdova S; Dravet C; Sotelo J
    Epilepsia; 1993; 34(6):1024-7. PubMed ID: 8243351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis.
    Del Brutto OH
    Neurology; 1994 Sep; 44(9):1706-9. PubMed ID: 7936301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The course of seizures after treatment for cerebral cysticercosis.
    Vazquez V; Sotelo J
    N Engl J Med; 1992 Sep; 327(10):696-701. PubMed ID: 1495522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel.
    Takayanagui OM; Jardim E
    Arch Neurol; 1992 Mar; 49(3):290-4. PubMed ID: 1536632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of neurocysticercosis.
    Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
    Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment of neurocysticercosis.
    Garg RK
    Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the course of neurocysticercosis modified by treatment with antihelminthic agents?
    Carpio A; Santillán F; León P; Flores C; Hauser WA
    Arch Intern Med; 1995 Oct; 155(18):1982-8. PubMed ID: 7575052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.
    Sotelo J; del Brutto OH; Penagos P; Escobedo F; Torres B; Rodriguez-Carbajal J; Rubio-Donnadieu F
    J Neurol; 1990 Apr; 237(2):69-72. PubMed ID: 2192018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurocysticercosis and praziquantel: long-term development in 100 patients].
    Spina-França A; Nóbrega JP; Machado LR; Livramento JA
    Arq Neuropsiquiatr; 1989 Dec; 47(4):444-8. PubMed ID: 2634386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
    Garcia HH; Del Brutto OH;
    Epilepsy Behav; 2017 Nov; 76():158-162. PubMed ID: 28606690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies in the treatment of seizures associated with neurocysticercosis.
    Singh G; Sharma R
    Epilepsy Behav; 2017 Nov; 76():163-167. PubMed ID: 28673685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis].
    Cohen L; Belec L; Sanson M; Pierrot-Deseilligny C; Signoret JL
    Rev Neurol (Paris); 1992; 148(1):58-61. PubMed ID: 1604116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
    Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ;
    Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial.
    Sotelo J; Escobedo F; Penagos P
    Arch Neurol; 1988 May; 45(5):532-4. PubMed ID: 3358706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis.
    Jung H; Hurtado M; Sanchez M; Medina MT; Sotelo J
    Clin Neuropharmacol; 1990 Dec; 13(6):559-64. PubMed ID: 2276121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis.
    Garcia HH; Pretell EJ; Gilman RH; Martinez SM; Moulton LH; Del Brutto OH; Herrera G; Evans CA; Gonzalez AE;
    N Engl J Med; 2004 Jan; 350(3):249-58. PubMed ID: 14724304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.
    Proaño JV; Madrazo I; García L; García-Torres E; Correa D
    J Neurosurg; 1997 Jul; 87(1):29-33. PubMed ID: 9202261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.
    Cruz M; Cruz I; Horton J
    Trans R Soc Trop Med Hyg; 1991; 85(2):244-7. PubMed ID: 1887483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.
    Garcia HH; Lescano AG; Gonzales I; Bustos JA; Pretell EJ; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
    Clin Infect Dis; 2016 Jun; 62(11):1375-9. PubMed ID: 26984901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J; Jung H
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.